Mobocertinib (Synonyms: AP32788, TAK-788) |
カタログ番号GC47697 |
モボセルチニブ (TAK-788) は、経口活性で不可逆的な EGFR/HER2 阻害剤です。 Mobocertinib は、活性化 EGFRex20ins 変異を含む発癌性バリアントを、野生型 EGFR よりも選択的に強力に阻害します。 Mobocertinib は、NSCLC 研究に使用できます。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1847461-43-1
Sample solution is provided at 25 µL, 10mM.
Mobocertinib is an inhibitor of mutant EGFR and HER2 receptors.1,2 It is selective for the HER2 exon 20 mutants HER2V659E, HER2G660D, HER2G309E, and HER2S310F over wild-type EGFR in Ba/F3 cells.1
1.Chouitar, J., Vincent, S., Brake, R., et al.TAK-788 is a novel and potent tyrosine kinase inhibitor with selective activity against EGFR/HER2AbstractsS811P2(13-32)(2018) 2.Neal, J., Doebele, R., Riely, G., et al.Safety, PK, and preliminary antitumor activity of the oral EGFR/HER2 exon 20 inhibitor TAK-788 in NSCLCAbstractsS599P1(13-44)(2018)
Average Rating: 5
(Based on Reviews and 33 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *